REVVITY INC(RVTY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVTY REVVITY INC

交易中 03-16 10:25:06 EDT

86.86

+1.29

+1.51%

最高87.87	最低86.47	成交量13.93万
今开86.47	昨收85.57	日振幅1.63%
总市值97.11亿	流通市值92.07亿	总股本1.12亿
成交额1,215万	换手率0.13%	流通股本1.06亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVTY","market":"US","secType":"STK","nameCN":"REVVITY INC","latestPrice":86.86,"timestamp":1773671103261,"preClose":85.57,"halted":0,"volume":139279,"delay":0,"changeRate":0.015075376884422185,"floatShares":106000000,"shares":111799374,"eps":2.068707,"marketStatus":"交易中","change":1.29,"latestTime":"03-16 10:25:06 EDT","open":86.4715,"high":87.87,"low":86.4715,"amount":12148543.921079999,"amplitude":0.016343,"askPrice":87.08,"askSize":227,"bidPrice":86.8,"bidSize":6,"shortable":3,"etf":0,"ttmEps":2.068707,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773691200000},"marketStatusCode":2,"adr":0,"listingDate":-141681600000,"exchange":"NYSE","adjPreClose":85.57,"dividendRate":0.003224,"preHourTrading":{"tag":"盘前","latestPrice":85.83,"preClose":85.57,"latestTime":"07:04 EDT","volume":2,"amount":171.66,"timestamp":1773659056855,"change":0.26,"changeRate":0.003038,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":85.57,"preClose":85.57,"latestTime":"16:43 EDT","volume":25798,"amount":2207519.45,"timestamp":1773434625049,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.843702,"impliedVol":0.4692,"impliedVolPercentile":0.8924},"requestUrl":"/m/hq/s/RVTY","defaultTab":"news","newsList":[{"id":"2613245276","title":"Revvity, Inc.涨0.09% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2613245276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613245276?lang=zh_cn&edition=full","pubTime":"2026-02-20 23:01","pubTimestamp":1771599683,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日23时01分，Revvity, Inc.股票出现波动，股价大幅拉升0.09%。Revvity, Inc.股票所在的生命科学行业中，整体跌幅为0.86%。其相关个股中，Ispecimen Inc.、Guardant Health, Inc.、Endra Life Sciences Inc.涨幅较大，Ispecimen Inc.、Grail, Inc.、Bioaffinity Technologies, Inc.较为活跃，换手率分别为71.38%、14.41%、2.52%，振幅较大的相关个股有Advanced Biomed Inc.、Ispecimen Inc.、燃石医学，振幅分别为17.50%、10.67%、10.39%。Revvity, Inc.公司简介：瑞孚迪是一家全球生命科学和诊断公司，成立于2023年，由珀金埃尔默更名而来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022023012395418847&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022023012395418847&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BN0W2V16.EUR","RVTY","BK4121","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4585","BK4588"],"gpt_icon":0},{"id":"2609135519","title":"Revvity, Inc.涨0.58% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2609135519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609135519?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:34","pubTimestamp":1770388473,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日22时34分，Revvity, Inc.股票出现异动，股价大幅上涨0.58%。Revvity, Inc.股票所在的生命科学行业中，整体涨幅为0.16%。其相关个股中，Ispecimen Inc.、Inotiv, Inc.、Personalis, Inc.涨幅较大，Ispecimen Inc.、Xwell, Inc.、Bioaffinity Technologies, Inc.较为活跃，换手率分别为91.25%、0.54%、0.19%，振幅较大的相关个股有Xwell, Inc.、Ispecimen Inc.、Check-Cap Ltd.，振幅分别为10.42%、10.29%、5.66%。Revvity, Inc.公司简介：瑞孚迪是一家全球生命科学和诊断公司，成立于2023年，由珀金埃尔默更名而来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020622343495402f9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020622343495402f9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","IE00BN0W2V16.EUR","RVTY","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4588","BK4585"],"gpt_icon":0},{"id":"1131022622","title":"REVVITY高管表示制药生物技术领域持续呈现积极趋势，涵盖最惠国协议、生物技术融资及并购环境","url":"https://stock-news.laohu8.com/highlight/detail?id=1131022622","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131022622?lang=zh_cn&edition=full","pubTime":"2026-02-02 21:45","pubTimestamp":1770039956,"startTime":"0","endTime":"0","summary":"REVVITY公司高管指出，当前制药与生物技术行业持续显现积极发展态势。这一趋势主要体现在最惠国待遇协议（MFN）的推进、生物技术领域融资活动的活跃以及并购市场环境的改善等多个维度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","RVTY","BK4588","IE00BN0W2W23.USD","BK4121","IE00BN0W2V16.EUR","BK4585"],"gpt_icon":0},{"id":"1112221094","title":"REVVITY高管透露成本效益措施预计将于2026年第二季度末全面落地","url":"https://stock-news.laohu8.com/highlight/detail?id=1112221094","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112221094?lang=zh_cn&edition=full","pubTime":"2026-02-02 21:35","pubTimestamp":1770039316,"startTime":"0","endTime":"0","summary":"REVVITY公司管理层近日透露，公司推行的成本优化方案预计将在2026年第二季度末前全面实施。该举措旨在通过系统性效率提升强化企业财务韧性，为长期战略布局提供支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4121","IE00BN0W2V16.EUR","RVTY","IE00BN0W2W23.USD","BK4588","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"1106908475","title":"REVVITY INC股价飙升至逾九个月高点，公司宣布将超越2025年盈利预测区间，尾盘大涨9.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106908475","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106908475?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:39","pubTimestamp":1768315161,"startTime":"0","endTime":"0","summary":"REVVITY INC股价强势突破九个月高位，此前该公司发布声明称其2025财年盈利表现将超出市场预期区间。这一利好消息推动股价盘中持续走强，最终录得9.1%的显著涨幅，展现出市场对该公司未来业绩的强烈信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","RVTY","BK4121","BK4588","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4585"],"gpt_icon":0},{"id":"1180282614","title":"REVVITY INC携手礼来 通过Xynthetica平台为生物技术公司提供预测模型访问资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1180282614","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180282614?lang=zh_cn&edition=full","pubTime":"2026-01-09 21:02","pubTimestamp":1767963741,"startTime":"0","endTime":"0","summary":"REVVITY INC宣布启动创新合作计划，该计划将专项资助参与合作的生物技术企业，使其能够通过REVVITY Signals的Xynthetica服务平台，直接获取制药巨头礼来公司开发的先进预测模型。\n这项合作旨在加速生物技术领域的研发进程，通过资金支持降低创新门槛。参与企业将获得技术准入资格，利用礼来经过验证的预测模型优化药物发现流程。REVVITY Signals的Xynthetica平台作为技术枢纽，将为模型部署和应用提供全流程支持。\n此次合作凸显了行业领先企业共同推动生物医药创新的承诺。通过资源共享与协同创新，有望为患者带来更高效的疗法，同时为参与方创造新的增长机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"51e6d18501975df584fd73dcbb421a75","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU1551013425.SGD","LU0266013472.USD","LU0417517546.SGD","LU0109394709.USD","IE00BK4W5L77.USD","LU1548497426.USD","LU2237443895.HKD","IE0005OL40V9.USD","LU0061475181.USD","LU1232071149.USD","IE00BN0W2W23.USD","LU0198837287.USD","LU1989771016.USD","LU0289739699.SGD","LU0058720904.USD","IE00BKPKM429.USD","LU2237443382.USD","SGXZ57979304.SGD","LU0640476718.USD","IE0004445239.USD","LU0109391861.USD","LU2471134523.USD","LU2471134879.HKD","BK4007","LU0882574055.USD","LU0114720955.EUR","LU0786609619.USD","LU1093756325.SGD","IE00BFSS8Q28.SGD","LU1623119135.USD","IE00BKDWB100.SGD","LU0238689110.USD","SG9999015986.USD","LU2746668974.SGD","LU2108987350.USD","LU2360106947.USD","LU0471298694.HKD","IE00BJJMRZ35.SGD","LU0683600562.USD","LU2750360641.GBP","LU0354030438.USD","LU0689472784.USD","LU0787776722.HKD","LU2168563687.JPY","LU2468319806.SGD","LU2089984988.USD","SGXZ81514606.USD","SGXZ31699556.SGD","LU0234572021.USD","SG9999018857.SGD","LU0256863811.USD","LU2087625088.SGD","LU2324357040.USD","LU2552382215.SGD","SG9999017495.SGD","LU0316494557.USD","BK4121","LU0466842654.USD","LU1061106388.HKD","IE00BK4W5M84.HKD","LU2168564149.EUR","BK4534","LU1720051017.SGD","LU0354030511.USD","IE0004445015.USD","IE00BN0W2V16.EUR","LU0882574139.USD","LU2552382058.USD","LU1974910355.USD","BK4581","LU2063271972.USD","IE00BJJMRX11.SGD","SG9999001176.USD","IE00BJT1NW94.SGD","LU1868837136.USD","IE00B1XK9C88.USD","LU0820561909.HKD","LU1868837300.USD","LU1127390331.HKD","IE00BFTCPJ56.SGD","LU0823416689.USD","LU0097036916.USD","LU2237443978.SGD","SG9999018865.SGD","IE0009355771.USD","LU1366192091.USD","LU2023250504.SGD","GB00BDT5M118.USD","LU1267930730.SGD","SG9999014898.SGD","LU2106854487.HKD","LU0096364046.USD","LU0820561818.USD","LU1804176565.USD","IE00B1BXHZ80.USD","LU0122379950.USD","LU0106261372.USD","LU2491050154.USD","SG9999015952.SGD","LU2168564495.EUR","IE00BWXC8680.SGD","LU0823434583.USD","LU2168564222.USD","LU2265009873.SGD","IE00BFSS7M15.SGD","LU1093756168.USD","BK4516","LU2417539215.USD","LU1814569148.SGD","LU2491049909.HKD","BK4585","IE00B775H168.HKD","LU2456880835.USD","LU2211815571.USD","LU0889565916.HKD","IE0002141913.USD","LU0471298777.SGD","LU1868836591.USD","LU1323610961.USD","LU0203201768.USD","BK4599","IE00BJJMRY28.SGD","LU0320765059.SGD","LU1035775433.USD","SG9999014906.USD","LU0203202063.USD","LU1983299246.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU2237443549.SGD","SG9999013999.USD","SGXZ99366536.SGD","LU0385154629.USD","IE00B4JS1V06.HKD","LU2264538146.SGD","LU2602419157.SGD","IE00BJLML261.HKD","LU2361044949.HKD","LU1291159041.SGD","LU2462157665.USD","LU2552382132.HKD","LU2471134796.USD","LU0708995401.HKD","LU2237443622.USD","LU2491050071.SGD","LU1988902786.USD","LU1023059063.AUD","LU0943347566.SGD","SGXZ51526630.SGD","LU1064131342.USD","LU0320765992.SGD","LU0225283273.USD","LU0353189763.USD","IE00B7KXQ091.USD","LU1069344957.HKD","LU2168564065.EUR","LU2461242641.AUD","LU0672654240.SGD","LU2237438978.USD","BK4588","LU0079474960.USD","LU1868836757.USD","LU2236285917.USD","LU1057294990.SGD","RVTY","LU2361045086.USD","LU0094547139.USD","LU0823434740.USD","LU1712237335.SGD","LU2471134952.CNY","LU0432979614.USD","BK4533","LU2357305700.SGD","LU2750360997.AUD","LU2746668461.USD","SG9999014914.USD","LU1917777945.USD","SG9999015945.SGD","LU1280957306.USD","LU1868836914.USD","LLY","LU1551013342.USD","LU2112291526.USD","SG9999001176.SGD","LU2361044865.SGD","SG9999014880.SGD","LU0323591593.USD","SG9999015978.USD","LU1720051108.HKD","LU0456855351.SGD","LU0256863902.USD","LU0353189680.USD","IE00BN29S564.USD","LU2237443465.HKD","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"1149633213","title":"REVVITY INC：Bofa Global Research将评级从“买入”下调至“中性”，目标价上调至110美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149633213","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149633213?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:11","pubTimestamp":1765800671,"startTime":"0","endTime":"0","summary":"REVVITY INC：Bofa Global Research将评级从“买入”下调至“中性”，并将目标价从105美元上调至110美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BN0W2T93.GBP","RVTY","BK4121","BK4585","IE00BN0W2W23.USD","IE00BN0W2V16.EUR"],"gpt_icon":0},{"id":"1104705928","title":"异动解读 | Revvity盘前大跌5.45%，第三季度营收不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1104705928","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104705928?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:06","pubTimestamp":1761563182,"startTime":"0","endTime":"0","summary":"医疗设备制造商Revvity今日盘前大跌5.45%，引发市场关注。截至盘前交易，该公司股价下跌至93.5美元。这一显著跌幅主要源于公司发布的第三季度财报未能达到市场预期。根据LSEG数据，Revvity第三季度营收为6.99亿美元，低于分析师预期的7.005亿美元。Revvity报告的第三季度每股利润为1.18美元，高于分析师平均预期的1.14美元。此外，公司重申了2-4%的有机增长目标，并将年度每股收益预期从之前的4.85美元至4.95美元上调至4.90美元至5.00美元。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RVTY"],"gpt_icon":0},{"id":"1119203465","title":"Revvity与Profluent携手推出AI增强的腺嘌呤脱氨酶精准碱基编辑系统","url":"https://stock-news.laohu8.com/highlight/detail?id=1119203465","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119203465?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:02","pubTimestamp":1758542530,"startTime":"0","endTime":"0","summary":"Revvity与Profluent携手推出AI增强的腺嘌呤脱氨酶精准碱基编辑系统","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","RVTY","BK4121","BK4588"],"gpt_icon":0},{"id":"2508800145","title":"Keybanc：维持Revvity(RVTY.US)评级，由增持调整至增持评级, 目标价由132.00美元调整至145.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508800145","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508800145?lang=zh_cn&edition=full","pubTime":"2025-02-03 21:51","pubTimestamp":1738590713,"startTime":"0","endTime":"0","summary":"Keybanc：维持Revvity(RVTY.US)评级，由增持调整至增持评级, 目标价由132.00美元调整至145.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/03215147941462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RVTY"],"gpt_icon":0},{"id":"2508748131","title":"Revvity, Inc.2024财年实现净利润2.83亿美元，同比增加57.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508748131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508748131?lang=zh_cn&edition=full","pubTime":"2025-02-03 00:00","pubTimestamp":1738512034,"startTime":"0","endTime":"0","summary":"2月3日，Revvity, Inc.公布财报，公告显示公司2024财年净利润为2.83亿美元，同比增加57.22%；其中营业收入为27.55亿美元，同比增加0.15%，每股基本收益为--。从资产负债表来看，Revvity, Inc.总负债47.26亿美元，其中短期债务242000.00美元，资产负债比为2.63，流动比率为3.60。机构评级：截至2025年2月3日，当前有17家机构对Revvity, Inc.目标价做出预测，其中目标均价为134.41美元，其中最低目标价为102.00美元，最高目标价为155.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203000037abc01292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203000037abc01292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVTY"],"gpt_icon":0},{"id":"1114824764","title":"异动解读 | Revvity 2024年Q4财报佳绩 盘前大涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114824764","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114824764?lang=zh_cn&edition=full","pubTime":"2025-01-31 21:02","pubTimestamp":1738328545,"startTime":"0","endTime":"0","summary":"今日盘前,Revvity Inc. (NYSE:RVTY)股价大涨6.03%,报收33.85美元。大涨的主要原因是公司公布的2024年第四季度财报超出市场预期。\n\nRevvity公司在财报中公布,2024年第四季度调整后每股收益1.42美元,高于分析师预期的1.37美元,同比增长13.6%;季度销售额达到7.29亿美元,也略高于预期的7.28亿美元,同比增长4.81%。优异的财报数据一定程度上反映了公司良好的发展态势和盈利能力。\n\n财报公布后,投资者对Revvity的未来增长前景抱有较高期待,从而推动了股价的大幅上涨。但需要关注的是,公司能否在未来持续保持高速增长,仍有待进一步观察。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RVTY"],"gpt_icon":0},{"id":"1142694126","title":"Revvity 2024年第四季度调整后每股收益 $1.42 超过预期 $1.37，销售额 $7.29372亿 超过预期 $7.28043亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1142694126","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142694126?lang=zh_cn&edition=full","pubTime":"2025-01-31 19:04","pubTimestamp":1738321457,"startTime":"0","endTime":"0","summary":"与去年同期的每股收益 $1.25 相比，这一数字增长了13.6%。公司报告季度销售额为 $7.29372亿，超过分析师普遍预期的 $7.28043亿，增长了0.18%。以上内容来自Benzinga Earnings专栏，原文如下：Revvity  reported quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.37 by 3.65 percent. This is a 13.6 percent increase over earnings of $1.25 per share from the same period last year.  The company reported quarterly sales of $729.372 million which beat the analyst consensus estimate of $728.043 million by 0.18 percent.  This is a 4.81 percent inc","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Revvity 2024年第四季度调整后每股收益 $1.42 超过预期 $1.37，销售额 $7.29372亿 超过预期 $7.28043亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY"],"gpt_icon":0},{"id":"2503058551","title":"Revvity, Inc.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503058551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503058551?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:46","pubTimestamp":1736779600,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时46分，Revvity, Inc.股票出现异动，股价快速拉升5.08%。Revvity, Inc.股票所在的生命科学行业中，整体涨幅为1.77%。Revvity, Inc.公司简介：Revvity 为制药、生物医学、化学、环境和一般工业市场提供仪器、测试、服务和软件解决方案。Revvity 提供产品和服务，其范围从基因筛选和环境分析工具到信息学和企业软件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113224640aba93528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113224640aba93528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","RVTY","BK4121"],"gpt_icon":0},{"id":"2483581323","title":"Revvity, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483581323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483581323?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:16","pubTimestamp":1731698174,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日03时16分，Revvity, Inc.股票出现波动，股价快速下挫5.04%。Revvity, Inc.股票所在的生命科学行业中，整体跌幅为3.87%。Revvity, Inc.公司简介：Revvity 为制药、生物医学、化学、环境和一般工业市场提供仪器、测试、服务和软件解决方案。Revvity 提供产品和服务，其范围从基因筛选和环境分析工具到信息学和企业软件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116031614a23bdf33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116031614a23bdf33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4121","BK4588","RVTY"],"gpt_icon":0},{"id":"1155060769","title":"异动解读 | Revvity业绩超预期 股价大涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155060769","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155060769?lang=zh_cn&edition=full","pubTime":"2024-11-05 06:20","pubTimestamp":1730758821,"startTime":"0","endTime":"0","summary":"医疗设备制造商Revvity Inc.今日股价盘中大涨6%,引发了市场的广泛关注。根据公司财报显示,尽管Revvity下调了2024财年收入预期,但其调整后每股收益预期却从4.70-4.80美元上调至4.83-4.87美元。此外,Revvity董事会还批准了一项为期两年、总额为10亿美元的新股票回购计划,这显示了公司对自身发展前景的信心。总的来看,公司超预期的业绩表现以及新股票回购计划等利好因素,使得投资者对Revvity的长期增长前景更加乐观,从而推动了股价的大幅上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RVTY"],"gpt_icon":0},{"id":"1190881963","title":"异动解读 | Revvity 下调2024年收入预期 推出新股票回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1190881963","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190881963?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:00","pubTimestamp":1730732425,"startTime":"0","endTime":"0","summary":"医疗设备制造商Revvity Inc.公布了新一年度财报预期,引发了市场的广泛关注。该公司作出了收入预期的下调,但同时也提高了利润预期并推出新的股票回购计划。Revvity预计2024财年全年收入将在27.5亿至27.7亿美元之间,较之前预期的27.7亿至27.9亿美元有所下调。尽管如此,Revvity第三季度营收和利润都超过了分析师预期。与此同时,Revvity董事会还批准了一项总额10亿美元、为期两年的新股票回购计划,以取代2023年剩余的6亿美元回购计划,显示出公司对自身前景的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RVTY"],"gpt_icon":0},{"id":"2480047584","title":"Revvity, Inc.盘中异动 早盘急速上涨5.00%报127.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480047584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480047584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:58","pubTimestamp":1730732326,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时58分，Revvity, Inc.股票出现波动，股价大幅拉升5.00%。Revvity, Inc.股票所在的生命科学行业中，整体涨幅为0.65%。Revvity, Inc.公司简介：Revvity 为制药、生物医学、化学、环境和一般工业市场提供仪器、测试、服务和软件解决方案。Revvity 提供产品和服务，其范围从基因筛选和环境分析工具到信息学和企业软件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225846971a42e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225846971a42e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RVTY","BK4585","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revvity.com","stockEarnings":[{"period":"1week","weight":-0.0632},{"period":"1month","weight":-0.1536},{"period":"3month","weight":-0.1485},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.2243},{"period":"ytd","weight":-0.1156}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revvity, Inc.在1947年于马萨诸塞州成立。该公司是健康科学解决方案、技术、专业知识和服务的领先供应商，提供从发现到开发、从诊断到治愈的完整工作流程。Revvity正在彻底改变医疗保健领域的可能性，在转化多组学技术、生物标志物识别、成像、预测、筛查、检测和诊断、信息学等方面拥有专门的重点领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.565217,"avgChangeRate":0.028629},{"month":2,"riseRate":0.630435,"avgChangeRate":0.005389},{"month":3,"riseRate":0.434783,"avgChangeRate":-0.010316},{"month":4,"riseRate":0.456522,"avgChangeRate":-0.003432},{"month":5,"riseRate":0.652174,"avgChangeRate":0.021853},{"month":6,"riseRate":0.413043,"avgChangeRate":0.004814},{"month":7,"riseRate":0.565217,"avgChangeRate":0.007009},{"month":8,"riseRate":0.521739,"avgChangeRate":0.006531},{"month":9,"riseRate":0.456522,"avgChangeRate":0.000154},{"month":10,"riseRate":0.586957,"avgChangeRate":0.014619},{"month":11,"riseRate":0.673913,"avgChangeRate":0.025718},{"month":12,"riseRate":0.586957,"avgChangeRate":0.022842}],"exchange":"NYSE","name":"REVVITY INC","nameEN":"REVVITY INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"REVVITY INC(RVTY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供REVVITY INC(RVTY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"REVVITY INC,RVTY,REVVITY INC股票,REVVITY INC股票老虎,REVVITY INC股票老虎国际,REVVITY INC行情,REVVITY INC股票行情,REVVITY INC股价,REVVITY INC股市,REVVITY INC股票价格,REVVITY INC股票交易,REVVITY INC股票购买,REVVITY INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"REVVITY INC(RVTY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供REVVITY INC(RVTY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}